Main clinical trials |
---|
Phase 2 open-label study R 668-AD1412 |
Pharmacokinetics, safety, efficacy in patients aged 6 to 17 years |
Liberty ADOL |
Phase 3 pilot monotherapy study R 668-AD 1526 |
Safety and efficacy in patients aged 12 to 17 years |
Liberty AD PED OLE |
Phase 3 study Open-Label Extension (OLE) R 668-AD 1434 |
Safety and efficacy in patients 6 months to <18 years |